pharmaphorum

MAY 25, 2021

One of the main reasons to use RWE is to counter a common criticism of the large phase 3 trials that for so long have been the ‘gold standard’ when developing drugs and gaining authorisations from regulators. The post AI, big data and real world evidence – the challenges and opportunities appeared first on.

Big Data 135

Big Data Clinical Research Research Trials 135

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

The Pharma Data

OCTOBER 25, 2020

BTI’s drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Trials 52

Trials Production FDA Approval Development 52

The Pharma Data

JANUARY 4, 2021

Barber’s work will give Kiromic a significant acceleration in the clinical development of its therapy platform and an even more significant advantage over its competitors. The pipeline development is leveraged through the Company’s proprietary target discovery engine called “DIAMOND.” “We believe Prof.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The TPO receptor agonist regulates blood platelet production by binding to and activating TPO receptors on megakaryocyte cells and inducing signalling cascades that increase platelet production.

Sales 98

Sales Manufacturing FDA Approval Life Science 98